Methods and compositions for the treatment of diverticulosis

Abstract

The present invention is directed to methods and compositions for the treatment of diverticulosis. It is more specifically directed to compositions including L-glutamine, its salts, or its derivatives, and uses of such compositions in the treatment of diverticulosis. In a method aspect, the present invention provides a method of treating diverticulosis. The method includes ingestion of 0.05 g/kg body weight to 10.0 g/kg body weight of L-glutamine, an L-glutamine salt or an L-glutamine derivative per day by a person who has diverticulosis.

1 . A method of treating diverticulosis, wherein the method comprises ingestion of 0.05 g/kg body weight to 10.0 g/kg body weight of L-glutamine, an L-glutamine salt or an L-glutamine derivative per day by a person who has diverticulosis. 
     
     
         2 . The method according to  claim 1 , wherein the compound ingested is L-glutamine. 
     
     
         3 . The method according to  claim 2 , wherein the L-glutamine is ingested as part of an aqueous solution or suspension. 
     
     
         4 . The method according to  claim 3 , wherein the L-glutamine is ingested for a period of at least six months. 
     
     
         5 . The method according to  claim 4 , wherein the number of diverticula in the person with diverticulosis is reduced by at least fifty percent. 
     
     
         6 . A composition for treating diverticulosis, wherein the composition comprises L-glutamine, an L-glutamine salt or an L-glutamine derivative and a fiber supplement. 
     
     
         7 . The composition according to  claim 6 , wherein the composition comprises L-glutamine. 
     
     
         8 . The composition according to  claim 7 , wherein the fiber is selected from a group of fibers consisting of methylcellulose, wheat dextrin and  psyllium.    
     
     
         9 . The composition according to  claim 8 , wherein the composition further comprises a flavorant. 
     
     
         10 . The composition according to  claim 9 , wherein it is in the form of a powder, a capsule, a caplet or a chewable tablet.